Diagnostics and Antimicrobial Treatment of Tuberculosis

Dear Colleagues,

Tuberculosis remains a global health priority, complicated by the rise in drug-resistant strains and the need for faster, more accurate diagnostic tools.

This Special Issue aims to provide a platform for high-quality research that addresses these challenges through innovation in both clinical and laboratory settings.

We are particularly interested in submissions covering the following topics:

• Advances in molecular and imaging diagnostics for M. tuberculosis.
• Innovative strategies for treating MDR-TB and XDR-TB.
• Pharmacokinetics and pharmacodynamics (PK/PD) of anti-tubercular agents.
• Novel drug discovery and host-directed therapies.
• Clinical management of TB/HIV co-infections and pediatric tuberculosis.

This Special Issue aims to bring together research addressing the multifaceted aspects of tuberculosis diagnostics and antimicrobial treatment, with a focus on optimizing diagnostic/therapeutic efficacy and mitigating the emergence of resistance. Contributions exploring active case findings, novel drug discovery, immunological aspects, and host-directed therapy, in both clinical and laboratory contexts, are particularly welcome.

By highlighting recent advances and ongoing challenges in tuberculosis diagnosis and treatment, this collection aims to support evidence-based clinical decision-making and contribute to the global strategy for the eradication of tuberculosis in the broader field of tuberculosis research and control.

Dr. Fabrizio Palmieri
Prof. Dr. Francesco Di Gennaro
Dr. Gina Gualano
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.